Evaluate the efficacy and safety of Ligashot inLigament injury (Knee sprain, Ankle sprain, Shoulder dislocation,Post-operative recovery) patients of Grade 1 and 2. - NI

Innovcare LifeSciences Pvt Ltd0 个研究点目标入组 30 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1. Male or female patients aged more than 18 years with grade 1 and 2 Ligament injury of knee,
•ankle or shoulder – with or without dislocation.
•2. Pain defined by a level of greater than or equal to 30 mm on a 100 mm Visual Analogue Scale
•3. Patient should have not participated in any other clinical trial during the past 3 months.
•4. Participants, who are willing to give written, signed and dated informed consent to participate in

•1. Prior knee ligament surgery of the involved knee;
•2. Torn or avulsed patellar or quadriceps tendon;
•3. Periarticular or long bone fracture that is anticipated to preclude weight-bearing after
•4. Require use of an external fixator for greater than 10 days;
•5. Planned staged surgical treatment;
•6. Unable to weight bear on the contralateral uninjured leg;
•7. Traumatic brain injury (TBI) that limits their ability to participate in their post-operative
•8. Surgical procedures that precludes early weight-bearing or range of motion.
•9. Any condition that would preclude the ability to comply with post-operative guidelines
•10. Moderate to severe renal impairment
•11. Pregnant or lactating
•12. History of hypersensitivity to any of the test products.
•13. Any condition decided as unfit for study by clinical investigator

发起方

Innovcare LifeSciences Pvt Ltd